Supply Chain

The Food and Drug Administration approved Faxitron's device to identify breast lumps for removal prior to surgery.

Allowing Medicare to negotiate drug prices is the most widely supported initiative to lower high drug costs among Americans, according to a new survey from Kaiser Family Foundation.

A majority of Americans, regardless of political affiliation, agree something must be done to address high drug costs, according to a new survey from Kaiser Family Foundation.

While health systems have focused on the high dollar supply areas to find savings within their hospitals for years, they're now finding significant untapped opportunities within their purchased services, according to Dina Salvaggio, a director at Chicago-based Prism Healthcare Partners.

Healthcare's movement toward value-based care is not only underscoring the importance of an efficient healthcare supply chain, but also redefining the supply chain leader role.

Supplies of the only U.S.-licensed yellow fever vaccine will be depleted by mid-2017 due to a manufacturing issue, reports the CDC in its most recent Morbidity and Mortality Weekly Report.

Medtronic's interest in selling off its $6 billion medical supplies unit to Cardinal Health piqued the interest of readers last month.

The Chartered Institute for Procurement and Supply developed an online supply chain risk-assessment tool, reports Supply Management.

A majority of supply chain leaders believe blockchain technology will reduce administrative work associated with supply chain management, according to a recent Xeneta survey.

Here are four latest drugs or medical devices approved by the Food and Drug Administration this week.